Serial Ketamine Infusions as an Adjunctive Therapy to Inpatient Care for Depression
About this episode
This episode features an interview with Declan M. McLoughlin discussing the use of serial ketamine infusions as a treatment for depression in inpatient settings.
Interview with Declan M. McLoughlin, PhD, author of Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression
More episodes of JAMA Psychiatry Author Interviews
- Yoga for Opioid Withdrawal and Autonomic Regulation
- Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions
- Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
- Predicting Adolescent Response to School-Based Mindfulness
- Tailored Weight Loss Programs for Adults With Serious Mental Illness
- Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations
Explore listener stats, chart rankings, contacts and more on the JAMA Psychiatry Author Interviews podcast page.